title: Effective treatment of hepatitis C virus infection with sofosbuvir and daclatasvir 90 mg in a patient with severe epilepsy on oxcarbazepine.
authors: Department of Pharmacy, Radboud university medical center, Geert Grooteplein Zuid 10, 6525 GA Nijmegen, The Netherlands. Electronic address: Elise.Smolders@radboudumc.nl.
authors: E J
authors: EJ
authors: Smolders
authors: Department of Pharmacy, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands.
authors: C T M M
authors: CT
authors: de Kanter
authors: Department of Pharmacy, Amphia Hospital, Molengracht 21, 4818 CK Breda, The Netherlands.
authors: N
authors: N
authors: van 't Veer
authors: Unit of Infectious Diseases, University of Turin, Department of Medical Sciences, Amedeo di Savoia Hospital, Corso Svizzera 164, Turin, Italy.
authors: A
authors: A
authors: D'avolio
authors: Unit of Infectious Diseases, University of Turin, Department of Medical Sciences, Amedeo di Savoia Hospital, Corso Svizzera 164, Turin, Italy.
authors: G
authors: G
authors: Di Perri
authors: Department of Pharmacy, Radboud university medical center, Geert Grooteplein Zuid 10, 6525 GA Nijmegen, The Netherlands.
authors: D M
authors: DM
authors: Burger
authors: Department of Internal Medicine, Amphia Hospital, Molengracht 21, 4818 CK Breda, The Netherlands.
authors: P
authors: P
authors: van Wijngaarden
mesh_terms: D000927:Anticonvulsants / Q000008:administration & dosage*; D000998:Antiviral Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics; D002219:Carbamates; D002220:Carbamazepine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D004827:Epilepsy / Q000150:complications* / Q000188:drug therapy*; D019698:Hepatitis C, Chronic / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage* / Q000493:pharmacokinetics; D008297:Male; D008875:Middle Aged; D000078330:Oxcarbazepine; D011759:Pyrrolidines; D000069474:Sofosbuvir / Q000008:administration & dosage* / Q000493:pharmacokinetics; D016896:Treatment Outcome; D014633:Valine / Q000031:analogs & derivatives
chemical_list: D000927:Anticonvulsants; D000998:Antiviral Agents; D002219:Carbamates; D007093:Imidazoles; D011759:Pyrrolidines; D002220:Carbamazepine; D014633:Valine; C549273:daclatasvir; D000078330:Oxcarbazepine; D000069474:Sofosbuvir